Clinical Scorecard: Lifetime Prevalence Among Women of Technology-Enabled Sexual Violence and Other Coercive Sexual Behaviors
At a Glance
Category
Detail
Condition
Lifetime technology-facilitated sexual violence (TFSV) and other coercive sexual acts among women in Iceland
Key Mechanisms
Surveyed experiences included unwanted sexual images or messages, unwanted requests for sexual images, persistent requests for dates or sex after repeated refusals, nonconsensual recording or distribution, stealthing, choking or suffocation during sex, and nonconsensual drugging. The persistent-request item was not expressly technology-specific.
Target Population
Icelandic-speaking women aged 18 to 69 invited to the cohort; the 2024 analytic sample included 14,358 women, with prevalence reported across age groups.
Care Setting
Nationwide cross-sectional survey of self-reported lifetime prevalence; the study does not provide clinical treatment guidance.
Key Highlights
The most frequently reported lifetime TFSV experience was receiving unwanted sexual images or messages (24.9%).
Lifetime prevalence was 18.1% for nonconsensual drugging, 6.0% for stealthing, and 5.0% for nonconsensual choking or suffocation during sex.
Reported prevalence was higher among younger participants; among women aged 23 to 34 years, 33.9% reported nonconsensual drugging, 15.2% stealthing, and 15.4% choking or suffocation.
In the 23-to-34-year group, 60.7% reported unwanted sexual images, 50.3% unwanted requests for sexual images, and 35.6% persistent requests for dates or sex despite refusals.
The authors identify recall and selection bias as limitations. Add other limitations only if verified in the full source.
Guideline-Based Recommendations
Diagnosis
The study estimated lifetime prevalence using participant reports of specified events; it does not provide clinical diagnostic criteria.
Management
The article does not provide individual treatment or management recommendations.
Monitoring & Follow-up
The authors call for repeated population-based assessments across countries to evaluate temporal and contextual variation and associated health consequences.
Risks
Potential recall and selection bias may affect prevalence estimates.
The persistent unwanted-request item did not expressly specify that the experience involved technology.
For suspected drugging, 1,551 participants responded “I suspect” and 1,043 responded “Yes”; do not infer perpetrator motivation unless supported by the full source.
Patient & Prescribing Data
No prescribing or treatment data were reported. The analytic sample comprised 14,358 women in Iceland; mean age was 50.3 years, and 99.5% identified as women.
The study reports prevalence of lifetime experiences, not medication use, treatment, or treatment outcomes.
Clinical Best Practices
This population-based prevalence study does not establish clinical best practices or provide recommendations for screening, treatment, or follow-up. Its findings may inform awareness of the range and frequency of reported experiences, but should not be interpreted as clinical guidance.
Related Resources & Content
JAMA Network Open, 2026 — Lifetime Prevalence of Technology-Facilitated Sexual Violence and Other Coercive Sexual Acts Against Women
Benítez-Hidalgo V, Henares-Montiel J, Ruiz-Pérez I, Pastor-Moreno G, 2025 — International Prevalence of Technology-Facilitated Sexual Violence Against Women: A Systematic Review and Meta-Analysis of Observational Studies
JAMA Network Open — A Pilot Study on Skills Development in Affective Recovery Through Video and Text Interventions for Survivors of Recent Sexual Assault
Journal of Medical Internet Research (JMIR) — Posttraumatic Symptoms as Predictors of Engagement With a Mobile App for Coping After Military Sexual Trauma: Public Usage Data Analysis Study
Frontiers in Psychiatry — An Evaluation of Disparities in Childhood Sexual Violence Among Women in Ghana: A Comparison of Data from 2008 and 2022 Utilizing the WHO Health Equity Assessment Toolkit
American Journal of Epidemiology — Factors Influencing Nonphysical Intimate Partner Violence: Insights from a Nationally Representative Survey in Canada
Technology Facilitated Violence against Women and Girls — Council of Europe Committee on Crime Problems
Care, courage, change: health-sector leadership in tackling violence against women and girls — WHO Regional Office for Europe
International Prevalence of Technology-Facilitated Sexual Violence Against Women: A Systematic Review and Meta-Analysis of Observational Studies - Vivian Benítez-Hidalgo, Jesús Henares-Montiel, Isabel Ruiz-Pérez, Guadalupe Pastor-Moreno, 2025
Lifetime Prevalence of Technology-Facilitated Sexual Violence and Other Coercive Sexual Acts Against Women | Women's Health | JAMA Network Open | JAMA Network
Non-consensual condom removal among adults:... | F1000Research
Characteristics of drug-facilitated sexual assault (DFSA): an observational study at a Danish sexual assault center | International Journal of Legal Medicine | Springer Nature Link
by Audrey R. Murchland, Edda Bjork Thordardottir, Arna Hauksdóttir, Jóhanna Jakobsdóttir, Marín Dögg Bjarnadóttir, Gunnar Tómasson, Rebecca B. Lawn, Thor Aspelund, Karestan C. Koenen, Unnur Anna Valdimarsdóttir